Survival nomogram for patients with de novo metastatic breast cancer based on the SEER database and an external validation cohort

Background: On average, 5–10% of patients are diagnosed with metastatic breast cancer (MBC) at the initial diagnosis. This study aimed to develop a nomogram to predict the overall survival (OS) in these patients. Methods: The nomogram was based on a retrospective study of 9435 patients with de novo...

Full description

Bibliographic Details

Main Authors:	Lizhi Ning, Yaobang Liu, Yujin Hou, Miaozhou Wang, Mingqiang Shi, Zhen Liu, Jiuda Zhao, Xinlan Liu
Format:	Artigo
Language:	Inglês
Published:	Elsevier 2023-10-01
Series:	Cancer Pathogenesis and Therapy
Subjects:	De novo metastatic breast cancer Overall survival SEER Nomogram
Online Access:	http://www.sciencedirect.com/science/article/pii/S2949713223000472
Tags:	Add Tag No Tags, Be the first to tag this record!